Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Carroll

Showing results (41-50 of 427) with videos related to

Pageof 43
Sort By:
Biotechnology Healthcare|February 8, 2013
Is the lynch mob coming for biotech?John Carroll
Biotechnology Healthcare|February 9, 2013
The new emphasis on safetyJohn Carroll
Biotechnology Healthcare|February 9, 2013
Enzyme replacement therapies: better lives versus the bottom lineJohn Carroll
Biotechnology Healthcare|February 21, 2013
Biotech cheers 4 more years, but familiar struggles still aheadJohn Carroll
Biotechnology Healthcare|February 21, 2013
Keeping the ball in boundsJohn Carroll
Biotechnology Healthcare|February 21, 2013
One drug, many usesJohn Carroll
Biotechnology Healthcare|February 21, 2013
Avian flu and the quest for immunity: not just chicken feedJohn Carroll
Managed Care (Langhorne, Pa.)|January 11, 2013
Insurers ready for exchanges; states--not so muchJohn Carroll
Biotechnology Healthcare|January 16, 2013
PDUFA Faces Rough ReauthorizationJohn Carroll
Managed Care (Langhorne, Pa.)|December 15, 2012
Lowball insurance plans fail to respond to Georgia's invitationJohn Carroll
Pageof 43

Showing results (41-50 of 427) with videos related to

Sort By:
Pageof 43
Biotechnology Healthcare|February 8, 2013
Is the lynch mob coming for biotech?John Carroll
Biotechnology Healthcare|February 9, 2013
The new emphasis on safetyJohn Carroll
Biotechnology Healthcare|February 9, 2013
Enzyme replacement therapies: better lives versus the bottom lineJohn Carroll
Biotechnology Healthcare|February 21, 2013
Biotech cheers 4 more years, but familiar struggles still aheadJohn Carroll
Biotechnology Healthcare|February 21, 2013
Keeping the ball in boundsJohn Carroll
Biotechnology Healthcare|February 21, 2013
One drug, many usesJohn Carroll
Biotechnology Healthcare|February 21, 2013
Avian flu and the quest for immunity: not just chicken feedJohn Carroll
Managed Care (Langhorne, Pa.)|January 11, 2013
Insurers ready for exchanges; states--not so muchJohn Carroll
Biotechnology Healthcare|January 16, 2013
PDUFA Faces Rough ReauthorizationJohn Carroll
Managed Care (Langhorne, Pa.)|December 15, 2012
Lowball insurance plans fail to respond to Georgia's invitationJohn Carroll
Pageof 43